- Release Date: 28/03/24 08:25
- Summary: First Patient Dosed in Phase 2 Stroke Trial of ARG-007
- Price Sensitive: Yes
- Download Document 289.42KB
Ann: First Patient Dosed in Phase 2 Stroke Trial of ARG-007
-
- There are more pages in this discussion • 49 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
77.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $98.63M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2500 | 78.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 80.0¢ | 11000 | 2 |
View Market Depth
| Last trade - 09.46am 04/11/2024 (20 minute delay) ? |
| AGN (ASX) Chart |
Day chart unavailable